Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Farnesyl diphosphate synthase | 0.016 | 1 | 0.5 |
Echinococcus granulosus | aminopeptidase N | 0.0085 | 0.3721 | 0.3721 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0055 | 0.1194 | 0.1194 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.004 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.016 | 1 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0055 | 0.1194 | 0.1194 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.016 | 1 | 1 |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.016 | 1 | 1 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0055 | 0.1194 | 0.1194 |
Leishmania major | carbonic anhydrase-like protein | 0.0055 | 0.1194 | 0.1194 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.016 | 1 | 1 |
Onchocerca volvulus | 0.0085 | 0.3721 | 0.5 | |
Loa Loa (eye worm) | polyprenyl synthetase | 0.016 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.004 | 0 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0055 | 0.1194 | 0.1194 |
Echinococcus multilocularis | carbonic anhydrase II | 0.0055 | 0.1194 | 0.1194 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.016 | 1 | 1 |
Entamoeba histolytica | bifunctional short chain isoprenyl diphosphate synthase, putative | 0.004 | 0 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.0055 | 0.1194 | 0.1194 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.016 | 1 | 0.5 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.016 | 1 | 1 |
Mycobacterium tuberculosis | Arylamine N-acetyltransferase Nat (arylamine acetylase) | 0.012 | 0.6661 | 0.6661 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0055 | 0.1194 | 0.1194 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.016 | 1 | 1 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.016 | 1 | 1 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthase, putative | 0.004 | 0 | 0.5 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.016 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.016 | 1 | 0.5 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.016 | 1 | 1 |
Echinococcus multilocularis | aminopeptidase N | 0.0085 | 0.3721 | 0.3721 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.004 | 0 | 0.5 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.004 | 0 | 0.5 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.016 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.016 | 1 | 0.5 |
Loa Loa (eye worm) | peptidase family M1 containing protein | 0.0069 | 0.2366 | 0.2366 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthetase, putative | 0.004 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.2986 | 0.2986 |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.004 | 0 | 0.5 |
Mycobacterium ulcerans | arylamine N-acetyltransferase Nat | 0.012 | 0.6661 | 0.6661 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1632 | 0.1632 |
Leishmania major | farnesyl pyrophosphate synthase | 0.016 | 1 | 1 |
Brugia malayi | Peptidase family M1 containing protein | 0.0085 | 0.3721 | 0.3721 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.016 | 1 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0055 | 0.1194 | 0.1194 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0055 | 0.1194 | 0.1194 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0055 | 0.1194 | 0.1194 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0055 | 0.1194 | 0.1194 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | = 48 uM | Concentration required to reduce the viability of mock-infected MT-4 cells | ChEMBL. | 7830280 |
CC50 (functional) | = 49 uM | Cellular cytotoxicity against HUT-78 cells. | ChEMBL. | 7562918 |
CC50 (functional) | = 49 uM | Cellular cytotoxicity against HUT-78 cells. | ChEMBL. | 7562918 |
EC50 (functional) | = 9.1301 uM | Concentration required to protect the virus infected cells against viral cytopathicity was measured on HIV-1(IIIB) virus strain in MT-4 cells | ChEMBL. | 7830280 |
EC50 (functional) | = 13.695 uM | Concentration required to protect the virus infected cells against viral cytopathicity was measured on HIV-2(ROD) virus strain in MT-4 cells | ChEMBL. | 7830280 |
Log 1/EC50 (functional) | = -1.14 | Antiretroviral activity against HIV-2 infected HUT-78 cells. | ChEMBL. | 7562918 |
Log 1/EC50 (functional) | = -0.96 | Antiretroviral activity against HIV-1 infected HUT-78 cells. | ChEMBL. | 7562918 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.